Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction

被引:220
作者
Summerfield, Scott G.
Read, Kevin
Begley, David J.
Obradovic, Tanja
Hidalgo, Ismael J.
Coggon, Sara
Lewis, Ann V.
Porter, Rod A.
Jeffrey, Phil
机构
[1] GlaxoSmithKline R&D, Dept Drug Metab & Pharmacokinet, Neurol & Gastrointestinal Ctr Excellence Drug Dis, Harlow CM19 5AW, Essex, England
[2] GlaxoSmithKline R&D, Dept Med Chem, Psychiat Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England
[3] GlaxoSmithKline R&D, Dept Drug Metab & Pharmacokinet, Psychiat Ctr Excellence Drug Discovery, Verona, Italy
[4] Kings Coll London, Pharmaceut Sci Res Div, London WC2R 2LS, England
[5] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England
[6] Absorpt Syst, Exton, PA USA
[7] UCB Celltech, Dept Drug Metab & Pharmacokinet, Cambridge, England
关键词
D O I
10.1124/jpet.107.121525
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dispositions of 50 marketed central nervous system ( CNS) drugs into the brain have been examined in terms of their rat in situ ( P) and in vitro apparent membrane permeability ( P app) alongside lipophilicity and free fraction in rat brain tissue. The inter- relationship between these parameters highlights that both permeability and brain tissue binding influence the uptake of drugs into the CNS. Hydrophilic compounds characterized by low brain tissue binding display a strong correlation ( R-2 = 0.82) between P and P-app, whereas the uptake of more lipophilic compounds seems to be influenced by both P-app and brain free fraction. A nonlinear relationship is observed between logP(oct) and P over the 6 orders of magnitude range in lipophilicity studied. These findings corroborate recent reports in the literature that brain penetration is a function of both rate and extent of drug uptake into the CNS.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 41 条
[1]  
ALAVIJEH S, 2005, NEURORX, V2, P554
[2]  
[Anonymous], 2003, American Journal of Drug Delivery
[3]   Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine [J].
Ardizzone, TD ;
Bradley, RJ ;
Freeman, AM ;
Dwyer, DS .
BRAIN RESEARCH, 2001, 923 (1-2) :82-90
[4]  
Begley DJ, 1999, ALFRED BENZON SYMP S, V45, P91
[5]   Cell cultures as tools in biopharmacy [J].
Braun, A ;
Hämmerle, S ;
Suda, K ;
Rothen-Rutishauser, B ;
Günthert, M ;
Krämer, SD ;
Wunderli-Allenspach, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S51-S60
[6]   HYDROGEN-BONDING POTENTIAL AS A DETERMINANT OF THE IN-VITRO AND IN-SITU BLOOD-BRAIN-BARRIER PERMEABILITY OF PEPTIDES [J].
CHIKHALE, EG ;
NG, KY ;
BURTON, PS ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1994, 11 (03) :412-419
[7]   CARRIER-MEDIATED TRANSPORT OF THE ANTITUMOR AGENT ACIVICIN ACROSS THE BLOOD-BRAIN-BARRIER [J].
CHIKHALE, EG ;
CHIKHALE, PJ ;
BORCHARDT, RT .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (07) :941-945
[8]   Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration [J].
Clark, DE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (08) :815-821
[9]   DIFFUSION OF SMALL NONELECTROLYTES ACROSS LIPOSOME MEMBRANES [J].
COHEN, BE ;
BANGHAM, AD .
NATURE, 1972, 236 (5343) :173-&
[10]   BLOOD-BRAIN INTERFACES IN VERTEBRATES - A COMPARATIVE APPROACH [J].
CSERR, HF ;
BUNDGAARD, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (03) :R277-R288